Banner

Human Thrombomodulin Antibody Pair - BSA and Azide free

Human Thrombomodulin Antibody Pair - BSA and Azide free (RMAB-0252179)

Cat. No.: RMAB-0252179

Category: Antibody Pair

INQUIRY 10 x 96 tests
The Antibody Pair can be used to quantify Human Thrombomodulin. BSA and Azide free antibody pairs include unconjugated capture and detector antibodies suitable for sandwich ELISAs. The antibodies are provided at an approximate concentration of 1 mg/mL as measured by the protein A280 method. The recommended antibody orientation is based on internal optimization for ELISA-based assays. Antibody orientation is assay dependent and needs to be optimized for each assay type. Both capture and detector antibodies are rabbit monoclonal antibodies delivering consistent, specific, and sensitive results._x000D_

Product Features

Conjugate Unconjugated capture and detector antibodies
Species Reactivity Human
Range 31.25 pg/mL - 2000 pg/mL
Applications Sandwich ELISA
Key Features Unconjugated capture and detector antibodies; Adaptable to any antibody pair-based assay format; Antibody concentration ~ 1 mg/mL; BSA and azide free buffer - ready for conjugation; Reacts with: Human

Target Information

Target Symbol THBD
Target Name Thrombomodulin
UniProt ID P07204
Cellular Localization Membrane.
Function Thrombomodulin is a specific endothelial cell receptor that forms a 1:1 stoichiometric complex with thrombin. This complex is responsible for the conversion of protein C to the activated protein C (protein Ca). Once evolved, protein Ca scissions the activated cofactors of the coagulation mechanism, factor Va and factor VIIIa, and thereby reduces the amount of thrombin generated.
Involvement in Disease Defects in THBD are the cause of thrombophilia due to thrombomodulin defect (THR-THBD). A hemostatic disorder characterized by a tendency to thrombosis.Defects in THBD are a cause of susceptibility to hemolytic uremic syndrome atypical type 6 (AHUS6). An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure andof episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. Note=Susceptibility to the development of atypical hemolytic uremic syndrome can be conferred by mutations in various components of or regulatory factors in the complement cascade system. Other genes may play a role in modifying the phenotype.
Post-translational Modifications N-glycosylated. The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains.
Sequence Similarities Contains 1 C-type lectin domain. Contains 6 EGF-like domains.

Storage & Shipping

Storage & Shipping Store at 4°C. Please refer to protocols.

For research use only. Not for clinical use.